|
 |
| PHARMACOLOGICAL STUDY |
|
| Year : 2015 | Volume
: 36
| Issue : 4 | Page : 432-436 |
|
|
Assessment of cytotoxicity of Portulaca oleracea Linn. against human colon adenocarcinoma and vero cell line
Prashant Y Mali
Department of Pharmacology, Sandip Institute of Pharmaceutical Sciences, Sandip Foundation, Nashik, Maharashtra, India
| Date of Web Publication | 16-Sep-2016 |
Correspondence Address:
Prashant Y Mali
Department of Pharmacology, Sandip Institute of Pharmaceutical Sciences, Sandip Foundation, Mahiravani, Trimbak Road, Nashik - 422 213, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-8520.190691
 Abstract | | |
Background: Portulaca oleracea Linn. (Portulacaceae) is commonly known as purslane in English. In traditional system it is used to cure diarrhea, dysentery, leprosy, ulcers, asthma, and piles, reduce small tumors and inflammations. Aim: To assess cytotoxic potential of chloroform extract of P. oleracea whole plant against human colon adenocarcinoma (HCT-15) and normal (Vero) cell line. Materials and Methods: Characterization of chloroform extract of P. oleracea by Fourier transform infrared (FTIR) spectroscopy was performed. Cytotoxicity (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay was used for assessment of cytotoxic potential of chloroform extract of P. oleracea. The concentrations of 1000–0.05 μg/ml were used in the experiment. Doxorubicin was considered as standard reference drug. Results: FTIR spectrum showed the peak at 1019.52 and 1396.21 center. The 50% cell growth inhibition (IC50) of chloroform extract of P. oleracea and doxorubicin was 1132.02 μg/ml and 460.13 μg/ml against human colon adenocarcinoma and 767.60 μg/ml and 2392.71 μg/ml against Vero cell line, respectively.Conclusion: Chloroform extract of P. oleracea whole plant was less efficient or does not have cytotoxic activity against human colon adenocarcinoma cell line. It was not safe to normal Vero cell line. But, there is a need to isolate, identify, and confirm the phytoconstituents present in extract by sophisticated analytical techniques. Keywords: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, Fourier transform infrared, human colon adenocarcinoma, Portulaca oleracea, purslane
How to cite this article:
Mali PY. Assessment of cytotoxicity of Portulaca oleracea Linn. against human colon adenocarcinoma and vero cell line. AYU 2015;36:432-6 |
| Introduction | |  |
Portulaca oleracea Linn. is a warm-climate, fleshy herbaceous succulent annual plant belonging to the Portulacaceae family.[1] It has a cosmopolitan distribution in Africa, China, India, Australia, Middle East, Europe, and the United States.[2],[3],[4]P. oleracea plant and its seeds are used in treating diseases of kidney and bladder, as strangury, dysuria, hematuria, gonorrhea, and lungs.
It is beneficial to the intestinal mucous membrane, relieves tormina, dysentery, and mucous diarrhea. Sour leaves are used as a vegetable. The seeds are said to be used as a vermifuge and to treat to dyspnea.[5],[6]P. oleracea is commonly known as Brihat Lonika, Lona, Loni, Ghoddhika, Ghotika, Upodika, Khursa in Ayurveda. It has properties and actions such as, Rasa (taste): Amla (sour); Guna (properties): Guru (heavy), Ruksa (dry), Sara; Virya (potency): Ushna (hot); Vipaka: Amla; Karma: Kaphahara, Pittakara, Vatahara, and Vanidoshahara.[7],[8]P. oleracea in ancient times was looked upon as one of the anti-magic herbs and strewn around a bed was said to afford protection against evil spirits and nightmares.[9]P. oleracea has reported to have more omega-3-fatty acids, alpha linoloic acid in particular than any other leafy vegetable plant.[10] It also contains Vitamins A, C, and E as well as dietary minerals such as calcium, potassium, magnesium, and iron, pigments, and betacyanins with potent antioxidants properties.[11],[12]
In vitro cytotoxicity testing has become an integral aspect of drug discovery because it is a convenient, cost-effective, and predictive means of characterizing the toxic potential of new chemical entities. The early and routine implementation of this testing is testament to its prognostic importance for humans.[13] Medicinal plants constitute a common alternative for cancer prevention and treatment worldwide.[14],[15],[16],[17] Approximately 60% of the anticancer drugs currently have been isolated from natural products. At this time, more than 3000 plants worldwide have been reported to possessed anticancer properties.[18] Therefore, based on the above considerations and to explore traditional use of this plant scientifically, author has assessed cytotoxicity of P. oleracea against human colon adenocarcinoma and normal cell line.
| Materials and Methods | | |
Chemicals
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) dye powder (Serva Electrophoresis), dimethyl sulfoxide cell culture grade (BioWorld), amphotericin B (HiMedia), penicillin and streptomycin solution stabilized (Sigma), ethylene di-amine tetra-acetic acid (EDTA; MP Biomedicals), DPBS/modified 1X (Dulbecoo's phosphate buffer saline without Ca + and Mg +) (HiMedia), fetal bovine serum (Quaditive), chloroform (SD Fine Chem). All other chemicals used for this experimental work were of analytical grade.
Instruments
Fourier transform infrared (FTIR) spectroscopy (Agilent Cary 630), biosafety cabinet Class II and cytotoxic safety cabinet (Esco), CO2 incubator (RS Biotech, mini galaxy A), deep freezer (Dairei), ELISA plate reader (Thermo), micropipettes (Eppendorf), RO water system (Millipore), chloroform (SD Fine Chem) 96-well microtiter plate (flat bottom, U bottom, V bottom), tissue culture flasks (75 cm 2 T Flask vented and 150 cm 2 T Flask vented), falcon tubes (15 ml, 50 ml), cryotubes (2 ml), etc.
Preparation of extract
The whole plant of P. oleracea was collected from the Khote Nagar of Jalgaon city, Maharashtra [Figure 1] and [Figure 2], was authenticated by taxonomist, Department of Botany, Dr. AGD Bendale Mahila Mahavidyalaya, Jalgaon, Maharashtra, India and herbarium specimen (No. Bot/14/129) was preserved. The plant was dried, powdered, and extracted with chloroform to get nonpolar cytotoxic phytoconstituents present in it using percolation method. The excess solvent was completely removed, get concentrated, and preserved in an airtight container under refrigeration. | Figure 2: Geographical distribution map of Portulaca oleracea in India (ENVIS database)
Click here to view |
Characterization of extract by Fourier transform infrared
The characterization of chloroform extract of P. oleracea was performed by FTIR spectrophotometer.
Procurement and maintenance of cell lines
Human colon adenocarcinoma (HCT-15) and normal (Vero) cell line were procured from National Centre for Cell Science, Pune. Stock cells of these cell lines were cultured in Dulbecco's modified eagles media, supplemented with 10% FBS. Along with media, cells were also supplemented with 5% Hanks' balanced salt solution, penicillin, streptomycin, and amphotericin B, in a humidified atmosphere of 5% CO2 at 37°C until confluence reached. The cells were dissociated with 0.2% trypsin, 0.02% EDTA in phosphate buffer saline solution. The stock cultures were grown initially in 25 cm 2 tissue culture flasks, then in 75 cm 2, and finally in 150 cm 2 tissue culture flask and cytotoxicity experiment was carried out in 96-well microtiter plates.
Cytotoxicity (3- [4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay
MTT assay is a sensitive, quantitative, and reliable colorimetric assay that measures viability, proliferation, and activation of cells. The assay is based on the capacity of mitochondrial dehydrogenase enzymes in living cells to convert the yellow water-soluble substrate MTT into a dark blue formazan product which is insoluble in water. The amount of formazan produced is directly proportional to the cell number in range of cell lines.[19] The protocol described by Mosmann with some modifications was adopted.[20],[21],[22],[23],[24],[25],[26] Briefly, cell lines in exponential growth phase were washed, trypsinized, and resuspended in complete culture media. Cells were seeded at a concentration of 2 × 104 cells/well in 96-well microtiter plate and incubated for 24 h during which a partial monolayer forms. The cells were then exposed to various concentrations of the test compounds and standard drug doxorubicin, (i.e., Conc. 1000–0.05 µg/ml). Control wells were received only maintenance medium. The plate was incubated at 37°C in humidified incubator with 5% CO2 and 75% relative humidity for 24 h. At the end of 24 h, 10 μl MTT labeling mixture was added and incubates for 4 h. The absorbance was measured using microplate ELISA reader at wavelength 590 nm. The percentage cell growth inhibition or percentage cytotoxicity was calculated by following formula:
% Viability = (AT − AB)/(AC − AB) ×100.
Where, AT = Absorbance of treated cells (drug), AB = Absorbance of blank (only media), and AC = Absorbance of control (untreated).
% Cell growth inhibition/% Cytotoxicity = 100% cell survival.
Statistical interpretation
All the values of percent cell growth inhibition was means of three independent observations (n = 3), and 50% cell growth inhibition (IC50) was determined by interpolating concentrations (X-axis) versus % cell inhibition (Y-axis) by linear regression method or equation using Microsoft Excel, 2007, Microsoft Corporation, USA application.
| Results | | |
FTIR spectrum of chloroform extract of P. oleracea showed the peak at 1019.52 and 1396.21 center at the wavelength region of 4000.00–650.00/cm and resolution 4/cm [Figure 3]. The peaks/centers corresponds to 1300–1000 (C–O stretching) alcohol and phenols, 1220–1020 (aliphatic C–N stretching) amines, 1300–1420 (C–H stretching in combination) organic compounds, 1430–1360 (oxygen-bonded complex) nitrogen or oxygen atom-containing compounds might be present in the extract. The 50% cell growth inhibition (IC50) of chloroform extract of P. oleracea and doxorubicin was 1132.02 µg/ml and 460.13 µg/ml against human colon adenocarcinoma cell line [Figure 4] and [Figure 5] and 767.60 µg/ml and 2392.71 µg/ml against normal cell line, respectively [Figure 6] and [Figure 7]. | Figure 3: Fourier transform infrared spectrum of chloroform extract of Portulaca oleracea
Click here to view |
 | Figure 4: % cell inhibition of chloroform extract of Portulaca oleracea against human colon adenocarcinoma cell line
Click here to view |
 | Figure 5: % cell inhibition of doxorubicin against human colon adenocarcinoma cell line
Click here to view |
 | Figure 6: % cell inhibition of chloroform extract of Portulaca oleracea against Vero cell line
Click here to view |
| Discussion | | |
Numerous cancer research for chemotherapeutic potential of medicinal plants has been carried out in an effort to discover new therapeutic agents that lack the toxic effects associated with current therapeutic agents.[27] Herbal medicines have been proven to be a major source of novel agents with various pharmaceutical applications.[28] The result of characterization of chloroform extract of P. oleracea by FTIR technique was in line with the above findings. Cytotoxicity assays are performed to predict potential toxicity, using cultured cells which may be normal or transformed cells. These tests normally involved short-term exposure of cultured cells to test substances, to detect how basal or specialized cell functions may be affected by the substance, before performing safety studies in whole organisms. It can also provide insight toward the carcinogenic and genotoxic dispositions of herb-derived compounds and extracts. The ability of a plant extract to inhibit cellular growth and viability can also be ascertained as an indication of its toxicity. Assessment parameters for cytotoxic effects include inhibition of cell proliferation, cell viability markers (metabolic and membrane), and morphologic and intracellular differentiation markers.[29] The results of our studies revealed that the 50% cell growth inhibition (IC50) of chloroform extract of P. oleracea and doxorubicin was 1132.02 µg/ml and 460.13 µg/ml, respectively, against human colon adenocarcinoma cell line. As per the United State National Cancer Institute Plant Screening Programme, a crude extract is generally considered to have in vitro cytotoxic activity if the IC50 value in carcinoma cells, following incubation between 48 and 72 h, is <20 μg/ml while it is <04 μg/ml for pure compounds.[30] The extract was less efficient or does not have cytotoxic activity as IC50 is more than the concentrations used in the study due to the nonextraction of nonpolar cytotoxic bioactive constituents into chloroform solvent or either not cytotoxic to HCT-15 cell line. The last main consideration in cytotoxicity testing is the manner in which cells die. The mechanism of death can be quite important if cytotoxicity testing is initiated for ancillary safety concerns (e.g. off-target cytotoxicity from pharmaceuticals, cosmetics, and nutritional supplements), or specifically, as for identifying new chemical entities for cancer therapy. Simply stated, compounds that cause primary necrosis in cell culture may carry unacceptable cytotoxic liabilities whereas compounds that cause apoptosis can be preferable.[31],[32],[33] Therefore, cytotoxic potential of chloroform extract of P. oleracea was also checked against normal cell line for its the safety.
| Conclusion | | |
It can be concluded that the chloroform extract was found to be toxic, and doxorubicin was safe with respect to the concentrations used against normal cell line. Further studies will not required on chloroform extract of P. oleracea whole plant using human colon adenocarcinoma and normal cell line. However, there is a need to isolate, identify, and confirm the phytoconstituents present in the extract using sophisticated analytical techniques which were found in the FTIR peak centers.
Acknowledgment
I would like to thank to Dr. Vipul P. Patel, Department of Pharmaceutical Biotechnology, S.K. Patel College of Pharmaceutical Education and Research, Ganpat University, Mehsana, Gujarat, and Dr. Ramprakash S. Gupta, Department of Zoology, Dr. AGD Bendale Mahila Mahavidyalaya, Jalgaon, Maharashtra, India, for providing the necessary facilities to the tenure of investigation.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Elkhayat ES, Ibrahim SR, Aziz MA. Portulene, a new diterpene from Portulaca oleracea L. J Asian Nat Prod Res 2008;10:1039-43.  |
| 2. | Chan K, Islam MW, Kamil M, Radhakrishnan R, Zakaria MN, Habibullah M, et al. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) Celak. J Ethnopharmacol 2000;73:445-51. |
| 3. | Oran SA, Al-Eisawi DM. Check list of medicinal plants in Jordan. Med Biol Sci 1998;25:84-112. |
| 4. | Mitich LW. Common purslane ( Portulaca oleracea). Weed. Technology 1997;11:394-7. |
| 5. | Nadkarni KM, Nadkarni AK. Indian Materia Medica with Ayurvedic, Unani-Tibbi, Siddha, Allopathic, Homeopathic, Naturopathic and Home Remedies. Revised Edition. Vol. I. Bombay: Popular Prakashan; 1999. |
| 6. | Drury CH. The Useful Plants of India: With Notices of Their Chief Value in Commerce, Medicine and the Arts. Madras: Higginbotham and Co.; 1873. |
| 7. | Anonymous. The Ayurvedic Pharmacopoeia of India, Monographs. Part I. Vol. II. New Delhi: Government of India, Ministry of Health and Family Welfare, Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH); 2007. p. 102-4. |
| 8. | Khare CP. Indian Medicinal Plants – An Illustrated Dictionary. New York: Springer; 2007. p. 513. |
| 9. | Maud G. A Modern Herbal: The Medicinal, Culinary, Cosmetic and Economic Properties, Cultivation and Folklore of Herbs, Grasses, Fungi, Shrubs and Trees with All Their Modern Scientific Uses. London: Tiger Books International; 1998. p. 600-20. |
| 10. | Kole PL, Jadhav HR, Thakurdesai P, Nagappa AN. The cosmetic potential of herbal extracts. Nat Prod Radiance 2005;4(4):315-21. |
| 11. | Ezekwe MO, Omara-Alwala TR, Membrahtu T. Nutritive characterization of purslane accessions as influenced by planting date. Plant Foods Hum Nutr 1999;54:183-91. |
| 12. | Anonymous. The Wealth of India: A Dictionary of Raw Materials and Industrial Products – (Raw Materials). Vol. IV New Delhi: Central Institute of Medicinal and Aromatic Plants; 2003. p. 219-20. |
| 13. | Niles AL, Moravec RA, Riss TL. In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening. Curr Chem Genomics 2009;3:33-41. |
| 14. | Mehta RG, Murillo G, Naithani R, Peng X. Cancer chemoprevention by natural products: How far have we come? Pharm Res 2010;27:950-61. |
| 15. | Desai AG, Qazi GN, Ganju RK, El-Tamer M, Singh J, Saxena AK, et al. Medicinal plants and cancer chemoprevention. Curr Drug Metab 2008;9:581-91. |
| 16. | Guilford JM, Pezzuto JM. Natural products as inhibitors of carcinogenesis. Expert Opin Investig Drugs 2008;17:1341-52. |
| 17. | Soobrattee MA, Bahorun T, Aruoma OI. Chemopreventive actions of polyphenolic compounds in cancer. Biofactors 2006;27:19-35. |
| 18. | Dai J, Mumper RJ. Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties. Molecules 2010;15:7313-52. |
| 19. | Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991;3:207-12. |
| 20. | Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. |
| 21. | Knick VC, Eberwein DJ, Miller CG. Vinorelbine tartrate and paclitaxel combinations: Enhanced activity against in vivo P388 murine leukemia cells. J Natl Cancer Inst 1995;87:1072-7. |
| 22. | Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12. |
| 23. | Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Victica D. New colorimetric cytotoxicity assay for anticancer agents. Eur J Cancer 1992;27:1162-8. |
| 24. | Mali PY. Cytotoxicity activities of chloroform extract of Cichorium intybus seed against HCT-15 and Vero cell line. Int J Health Allied Sci 2015;4:267-70.  |
| 25. | Mali PY, Gaikwad S. In vitro cytotoxicity study of Cichorium intybus seed using NCIH-522 cell line by MTT assay. Adv Pharmacol Toxicol 2015;16(2):49-56. |
| 26. | Mali PY. Cytotoxicity study of methanolic extract of Euphorbia hirta using HCT-15 and Vero cell line. Inventi Impact: Ethnopharmacology 2016;1(1):10-13. |
| 27. | Scheck AC, Perry K, Hank NC, Clark WD. Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells. BMC Complement Altern Med 2006;6:27. |
| 28. | Mishra BB, Tiwari VK. Natural products: An evolving role in future drug discovery. Eur J Med Chem 2011;46:4769-807. |
| 29. | O'Brien P, Haskings JR. In vitro cytotoxicity assessment. High content screening. Methods Mol Biol 2006;356:415-25. |
| 30. | Boik J. Natural Compounds in Cancer Therapy. Minnesota, USA: Oregon Medical Press; 2001. |
| 31. | Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005;73:1907-16. |
| 32. | Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15. |
| 33. | Wyllie AH, Kerr JF, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]
|
